Rheumatoid arthritis (RA) is considered a chronic disease that cannot be cured. Biologic
agents have enabled good therapeutic successes; however, the response to biologic …

Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …

Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

Background Early intervention and tight control of inflammation optimise outcomes in
rheumatoid arthritis but these approaches have not yet been studied in psoriatic arthritis. We …

The management of multiple sclerosis is becoming increasingly complex with the
emergence of new and more effective disease-modifying therapies (DMT). We propose a …

Disease-modifying treatments for early and advanced multiple... : Current Opinion in Neurology
Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment …

Objective To test the effectiveness of a telehealth service delivery model for the treatment of
children with attention-deficit/hyperactivity disorder (ADHD) that provided pharmacological …

Objective To evaluate whether a disease activity guided strategy of dose reduction of two
tumour necrosis factor (TNF) inhibitors, adalimumab or etanercept, is non-inferior in …

Rheumatoid arthritis (RA) is a systemic autoimmune disease that primarily causes
inflammation of the joints. The prevalence of RA is 1%, with a greater predominance in …

Early diagnosis, standardized treatment, and regular monitoring are the clinical treatment
principle of rheumatoid arthritis (RA). The overarching principles and recommendations of …